At the just-held Global Track & Trace meeting (Ringoes, NJ; Oct. 25), representatives from AmerisourceBergen presented a radically new approach to serialization and e-pedigree, the long-sought measures to secure pharma distribution against counterfeiting and diversion. The proposal: serialize only to […]

A world of trouble and complications are coming to bear on Xyrem (gamma hydroxybutyrate, or GHB), an orphan drug indicated for narcolepsy, marketed by Jazz Pharmaceuticals (Palo Alto, CA). The drug, a powerful depressant, is a DEA-listed Schedule III narcotic, […]